NCT05799404 is a clinical trial of ultra-high resolution CT in Otosclerosis, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT05799404?

NCT05799404 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT05799404?

Interventions in NCT05799404: ultra-high resolution CT.

What condition does NCT05799404 study?

NCT05799404 studies Otosclerosis, Otitis Media.

Is NCT05799404 still recruiting?

NCT05799404 is currently status unknown. Last updated 5 April 2023.

Last reviewed 2023-04-05 · How we verify

NCT05799404

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stapes Footplate Thickness Measured With UHR-CT

Status unknown Last updated 5 April 2023

What this trial tests

trial testing ultra-high resolution CT in Otosclerosis in 100 participants. Status unknown.

Timeline

28 April 2023

Primary endpoint
28 June 2023

28 June 2023

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	28 April 2023
Primary completion	28 June 2023
Estimated completion	28 June 2023

Drugs / interventions tested

ultra-high resolution CT

Conditions studied

Otosclerosis — all drugs for Otosclerosis →
Otitis Media — all drugs for Otitis Media →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with Otosclerosis or Otitis Media. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the thickness of the stapes footplate measured with ultra high resolution CT in control patients, otosclerosis patients and chronic otitis media patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05799404 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 5 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05799404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing